Free Trial

Avanos Medical Q3 2023 Earnings Report

Avanos Medical logo
$14.16 -0.24 (-1.67%)
As of 03:58 PM Eastern

Avanos Medical EPS Results

Actual EPS
$0.30
Consensus EPS
$0.29
Beat/Miss
Beat by +$0.01
One Year Ago EPS
$0.38

Avanos Medical Revenue Results

Actual Revenue
$171.30 million
Expected Revenue
$169.60 million
Beat/Miss
Beat by +$1.70 million
YoY Revenue Growth
-0.60%

Avanos Medical Announcement Details

Quarter
Q3 2023
Time
Before Market Opens

Conference Call Resources

Remove Ads

Avanos Medical Earnings Headlines

Avanos Medical Q3 EPS Estimate Decreased by Zacks Research
Q1 EPS Estimates for Avanos Medical Reduced by Analyst
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.
StockNews.com Upgrades Avanos Medical (NYSE:AVNS) to "Buy"
Avanos Medical Names David Pacitti as Next CEO
Avanos names David Pacitti as CEO, effective April 14
See More Avanos Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Avanos Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Avanos Medical and other key companies, straight to your email.

About Avanos Medical

Avanos Medical (NYSE:AVNS), a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

View Avanos Medical Profile

More Earnings Resources from MarketBeat